Lincoln Pharmaceuticals Limited (LINCOLN.NS)

Home
LINCOLN.NS
Financials

666.7 (INR) • At close November 8, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Revenue Numbers are in millions	5,805.496	5,103.088	4,681.974	4,147.479	3,768.406	3,569.195	3,549.997	3,606.426	4,001.504	2,660.745	2,112.669	1,928.787	1,754.566	1,826.866	1,267.284	1,144.412	862.319
Cost of Revenue Numbers are in millions	3,918.63	2,413.969	2,197.872	1,988.822	1,837.471	1,764.792	1,935.978	2,371.769	2,959.257	1,909.816	1,463.287	1,323.614	1,172.239	1,277.466	783.691	1,047.83	768.634
Gross Profit Numbers are in millions	1,886.866	2,689.119	2,484.102	2,158.657	1,930.935	1,804.403	1,614.018	1,234.657	1,042.247	750.928	649.383	605.174	582.326	549.4	483.592	96.582	93.685
Gross Profit Ratio Numbers are in millions	0.325	0.527	0.531	0.52	0.512	0.506	0.455	0.342	0.26	0.282	0.307	0.314	0.332	0.301	0.382	0.084	0.109
Reseach & Development Expenses Numbers are in millions	109.712	117.691	0	93.632	82.996	89.383	70.916	52.979	55.88	45.995	30.964	30.018	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	1,031.41	933.297	178.192	138.246	113.673	107.176	75.867	26.834	130.755	95.639	61.07	65.794	80.563	80.713	73.683	0	0
Selling & Marketing Expenses Numbers are in millions	42.776	48.085	251.542	229.117	244.128	177.372	187.632	248.817	217.874	220.524	190.325	210.426	205.753	224.649	187.008	0	0
SG&A Numbers are in millions	994.016	981.382	429.734	367.363	357.801	284.548	263.499	275.651	348.629	316.163	251.395	276.22	286.315	305.362	260.691	0	0
Other Expenses Numbers are in millions	344.225	224.729	99.977	56.639	0.011	0.16	3.001	536.983	330.821	209.43	218.132	181.619	175.663	129.885	115.025	5.956	6.813
Operating Expenses Numbers are in millions	994.016	1,888.749	1,600.167	1,361.945	1,323.126	1,190.06	1,139.75	812.634	679.451	525.593	469.527	457.838	461.978	435.247	375.716	5.956	6.813
Operating Income Numbers are in millions	892.85	805.469	876.979	798.009	583.389	608.204	474.268	422.023	362.796	225.335	179.855	147.335	120.348	114.153	107.877	90.626	86.872
Operating Income Ratio Numbers are in millions	0.154	0.158	0.187	0.192	0.155	0.17	0.134	0.117	0.091	0.085	0.085	0.076	0.069	0.062	0.085	0.079	0.101
Total Other Income Expenses Net Numbers are in millions	329.576	199.329	82.414	39.199	88.937	13.742	-11.798	-53.592	-32.141	-26.878	-59.142	-33.496	-46.465	-31.798	-22.04	-19.944	-21.67
Income Before Tax Numbers are in millions	1,222.426	1,004.798	959.394	837.205	672.324	621.945	462.471	368.43	330.655	198.457	120.713	113.84	73.883	82.355	85.837	70.682	65.202
Income Before Tax Ratio Numbers are in millions	0.211	0.197	0.205	0.202	0.178	0.174	0.13	0.102	0.083	0.075	0.057	0.059	0.042	0.045	0.068	0.062	0.076
Income Tax Expense Numbers are in millions	289.377	275.805	265.843	214.708	157.661	134.557	115.977	97.54	92.658	48.043	18.867	18.497	22.603	23.857	24.793	0	18.576
Net Income Numbers are in millions	933.049	728.993	693.55	622.501	514.394	487.101	346.23	270.648	236.823	150.121	106.543	96.623	51.188	41.664	61.043	70.682	46.626
Net Income Ratio Numbers are in millions	0.161	0.143	0.148	0.15	0.137	0.136	0.098	0.075	0.059	0.056	0.05	0.05	0.029	0.023	0.048	0.062	0.054
EPS Numbers are in millions	46.58	36.4	34.63	31.08	25.72	24.36	17.31	15.73	14.52	9.2	6.53	5.92	3.14	3.02	6.71	5.72	6.13
EPS Diluted Numbers are in millions	46.58	36.4	34.63	31.08	25.72	24.36	17.31	15.73	14.16	9.2	6.53	5.92	3.14	3.02	6.71	5.72	6.13
EBITDA Numbers are in millions	999.097	1,116.76	1,020.899	895.631	768.314	717.818	570.32	491.787	453.363	317.709	215.346	155.996	122.408	130.821	119.482	99.253	93.939
EBITDA Ratio Numbers are in millions	0.172	0.219	0.218	0.216	0.204	0.201	0.161	0.136	0.113	0.119	0.102	0.081	0.07	0.072	0.094	0.087	0.109

Lincoln Pharmaceuticals Limited

NSE:LINCOLN.NS Add to watchlist

NSE:LINCOLN.NS